A roadmap for translational cancer glycoimmunology at single cell resolution

Abstract Cancer cells can evade immune responses by exploiting inhibitory immune checkpoints. Immune checkpoint inhibitor (ICI) therapies based on anti-CTLA-4 and anti-PD-1/PD-L1 antibodies have been extensively explored over the recent years to unleash otherwise compromised anti-cancer immune respo...

Full description

Bibliographic Details
Main Authors: Andreia Peixoto, Andreia Miranda, Lúcio Lara Santos, José Alexandre Ferreira
Format: Article
Language:English
Published: BMC 2022-04-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
Online Access:https://doi.org/10.1186/s13046-022-02335-z